| Charles L Reese, MD | |
|
4755 Ogletown-stanton Road, Newark, DE 19718-0001 | |
| (302) 733-1000 | |
| (302) 733-1633 |
| Full Name | Charles L Reese |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 4755 Ogletown-stanton Road, Newark, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942272232 | NPI | - | NPPES |
| 0000038201 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C10001965 (Delaware) | Primary |
| Entity Name | Doctors For Emergency Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750369674 PECOS PAC ID: 0648160341 Enrollment ID: O20040317000490 |
News Archive
Healthy cells normally undergo cell division, but when a genetic mutation causes uncontrolled cell growth, they form a tumor. Cancer is one of the leading causes of death worldwide, and most deaths happen when cancer cells start to metastasize or travel from the mother tumor to other parts of the body.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces that a recent study provides new evidence for anti-cirrhotic effects of GFT505 in the context of NASH.
Gen-Probe announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for repeat biopsies in men suspected of having prostate cancer.
Zimmer Holdings, Inc., a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting. The Continuum Cup combines the best of Zimmer's proven hip technologies – Trabecular Metal™ Technology, Metasul® Metal-on-Metal technology, BIOLOX® delta and Longevity® Highly Crosslinked Polyethylene – with new innovations in what is now the company's most versatile acetabular cup system.
Researchers at The Wistar Institute have identified a key gene (KLF17) involved in the spread of breast cancer throughout the body. They also demonstrated that expression of KLF17 together with another gene (Id1) known to regulate breast cancer metastasis accurately predicts whether the disease will spread to the lymph nodes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles L Reese, MD Po Box 3048, Wilmington, DE 19804-0048 Ph: (302) 224-5678 | Charles L Reese, MD 4755 Ogletown-stanton Road, Newark, DE 19718-0001 Ph: (302) 733-1000 |
News Archive
Healthy cells normally undergo cell division, but when a genetic mutation causes uncontrolled cell growth, they form a tumor. Cancer is one of the leading causes of death worldwide, and most deaths happen when cancer cells start to metastasize or travel from the mother tumor to other parts of the body.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces that a recent study provides new evidence for anti-cirrhotic effects of GFT505 in the context of NASH.
Gen-Probe announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for repeat biopsies in men suspected of having prostate cancer.
Zimmer Holdings, Inc., a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting. The Continuum Cup combines the best of Zimmer's proven hip technologies – Trabecular Metal™ Technology, Metasul® Metal-on-Metal technology, BIOLOX® delta and Longevity® Highly Crosslinked Polyethylene – with new innovations in what is now the company's most versatile acetabular cup system.
Researchers at The Wistar Institute have identified a key gene (KLF17) involved in the spread of breast cancer throughout the body. They also demonstrated that expression of KLF17 together with another gene (Id1) known to regulate breast cancer metastasis accurately predicts whether the disease will spread to the lymph nodes.
› Verified 6 days ago
Dr. Sepehr Sedigh Haghighat, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-3901 | |
Paul C Anderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogeltown Stanton Road, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 | |
Valerie Ann Cohen, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-623-4050 | |
Brian E Burgess, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Road, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 | |
Kristina Louise Stransky, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1042 | |
Dr. John Thomas Powell, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Christiana Hospital Academic Affairs, Suite 2a00, Newark, DE 19718 Phone: 302-733-1557 | |
Dr. Jennifer Terrano Mink, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Christiana Hospital C/o Emergency Medicine Suite 1071, Newark, DE 19718 Phone: 302-733-1840 Fax: 302-733-1633 |